We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Database to Reduce Dosing Errors in Infants

By HospiMedica staff writers
Posted on 12 Dec 2002
To reduce medication errors, a new software database offers recommendations on drug dosage for newborns and infants and displays a warning message when dose range or frequency is exceeded.

The software is designed to prevent dosing errors in neonates and infants by factoring in two critical patient characteristics: weight and gestational age at birth. More...
The module offers recommendations on how high or low a dose should be given, what the maximum daily dose should be, how often a dose should be given, and how long the patient should remain on the drug. Considered in the recommendations are kidney and liver function and how rapidly the body is metabolizing certain marker enzymes. Warning messages alert healthcare workers when a prescribed dose or frequency of administration falls outside an acceptable range.

Medication errors caused by out-of-range dosages are among the most common mistakes, and pediatric patients may be more vulnerable to adverse outcomes from drug errors than adult patients, says First DataBank (San Bruno, CA, USA), which developed the software. The software module, called Neonatal and Infant Dosage Range Check Module, can be used with the company's Drug Information Framework for quick implementation.

"Our unique content adds a new level of sophistication to medication screening for hospitals with neonatal and infant patients,” said Dennis Hays, manager of clinical services at First DataBank.




Related Links:
First DataBank

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.